Patrice Milos

Patrice Milos is a biotech CEO with a PhD in molecular genetics and biology from Rensselaer Polytechnic and over 25 years of industry experience as an entrepreneur and senior executive operating at the intersection of genomics and medicine in companies focused on translational science ranging from start-ups to global pharmaceutical leaders.

As an expert on precision care and translational sciences across multiple therapeutic areas, she also serves as an NIH grant reviewer and sits on the tech advisory boards of Creyon Bio, Paradigm4, Binx Health, UltraPlaCad, and SeqLL.